Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting | 2022 Evolution Conference

Many larger academic cancers now use total neoadjuvant therapy, or TNT, as a treatment option for patients with locally advanced rectal cancer. In this session, Dr Laura Van Metre Baum from Yale Cancer Center discusses some of the unique aspects of using the TNT approach for rectal cancer in the community setting.

To obtain credit for this CME activity you must watch the full 2022 Evolution Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.